Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-09-018832
Filing Date
2009-04-02
Accepted
2009-04-02 19:38:00
Documents
2
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 - MICHAEL NARACHI 3-31-2009 rrd238647.html 3  
1 FORM 3 - MICHAEL NARACHI 3-31-2009 rrd238647.xml 3 2149
2 POWER OF ATTORNEY rrd214002_242076.htm EX-24.1 3264
  Complete submission text file 0001181431-09-018832.txt   7267
Mailing Address C/O ADVANCED MAGNETICS, INC. 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address
NARACHI MICHAEL (Reporting) CIK: 0001380022 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33415 | Film No.: 09729638

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations